|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 560 20th Street |
Address2 |
|
City | San Francisco |
State | CA |
Zip Code | 94107 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 401104897-12
|
||||||||
|
6. House ID# 441030001
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jim R. Esquea |
Date | 7/20/2020 8:00:04 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 7610/S.___, Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act, FY 2021; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including implementation of a national track and trace system to ensure enforcement against illicit trade;
H.R. ___/S.___, Labor, Health and Human Services, and Related Agencies Appropriations Act, FY2021; discussions related to the correlation between vitamin E acetate and the EVALI cases.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kaitlyn |
Boecker |
|
|
|
Benjamin |
Branch |
|
|
|
Chaka |
Burgess |
|
|
|
Jim |
Esquea |
|
|
|
Alexander |
Maggos |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Regulation of electronic nicotine delivery system products as a less harmful alternative for adult smokers;
Issues related to enforcement of illicit tobacco products, including importation of counterfeit products;
Issues related to taxation and user fees for tobacco products;
H.R. 293, Youth Vaping Prevention Act of 2019;
H.R. 1498/S. 655, SAFE Kids Act;
H.R. 1642/S. 1965, Combating the Illicit Trade in Tobacco Products Act;
H.R. 1897/S. 916, MOMMAs Act; provisions related to taxation of tobacco products;
H.R. 2084, SCOTT Act of 2019;
H.R. 2111/S. 1048, PROTECT Act;
H.R. 2339/S.3174, Reversing the Youth Tobacco Epidemic Act;
H.R. 3942/S. 1253, Preventing Online Sales of E-Cigarettes to Children Act;
H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019;
H.R. 5721/S. 3223, Resources to Prevent Youth Vaping Act;
H.R. 6637, Health Equity and Accountability Act of 2020; provisions related to taxation of tobacco products;
S. 616, E-cigarette Youth Protection Act;
S. 2517, Tobacco Tax Equity Act of 2019;
S. 2519, Prohibiting Non-tobacco E-cigarette Flavors; and
S. 2536, E-Cigarette Device Standards Act of 2019.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kaitlyn |
Boecker |
|
|
|
Benjamin |
Branch |
|
|
|
Chaka |
Burgess |
|
|
|
Jim |
Esquea |
|
|
|
Alexander |
Maggos |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |